Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘22
3726
1 4 3 69.2%
3727
1 15 14 21.2%
3728
1 1 0 42.7%
NGEN
3729
NervGen Pharma Corp. Common stock
NGEN
$448M
1 1 0
3730
1 1 0
3731
1 1 0
3732
1 1 0 54.8%
3733
1 7 6 0.7%
3734
1 18 17 5.55%
3735
1 13 12 87.2%
EQIN
3736
Columbia U.S. Equity Income ETF
EQIN
$259M
1 3 2 26.2%
3737
1 7 6 97.2%
3738
1 1 0 100%
3739
1 17 16 71.4%
3740
1 6 5 1.14%
3741
1 14 13 36.9%
3742
1 1 0 55.6%
3743
1 8 7 15.8%
3744
1 4 3 7.08%
3745
1 2 1 4.09%
3746
1 9 8 75.4%
3747
1 1 0 5.65%
3748
1 2 1 40.4%
3749
1 17 16 81.4%
3750
1 4 3 16.2%